Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Condition: Crohn Disease Intervention: Biological: infliximab, adalimumab Sponsors: Connecticut Children's Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emory University; Children's Hospital Medical Center, Cincinnati; University of North Carolina, Chapel Hill Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials